期刊
JOURNAL OF IMMUNOLOGY
卷 170, 期 9, 页码 4427-4431出版社
AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.170.9.4427
关键词
-
类别
CD8(+) effector T cells recognize malignant cells by monitoring their surface for the presence of tumor-derived-peptides bound to MHC class I molecules. In addition, tumor-derived-Ags can be cross-presented to CD8(+) effector T cells by APCs. IFN-gamma production by CD8(+) T cells is often critical for tumor rejection. However, it remained unclear whether 1) CD8(+) T cells secrete IFN-gamma in response to Ag recognition on tumor cells or APCs and 2) whether IFN-gamma mediates its antitumor effect by acting on host or tumor cells. We show in this study that CD8(+) effector T cells can reject tumors in bone marrow-chimeric mice incapable of cross-presenting Ag by bone marrow-derived APCs and that tumor rejection required host cells to express IFN-gammaR. Together, CD8(+) effector T cells recognize Ag directly on tumor cells, and this recognition is sufficient to reject tumors by IFN-gamma acting on host cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据